Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period

ATRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth

ATRA Quick Ratio for Trailing Twelve Months Period

(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Current Liabilities Growth 25.42 % 71.11 % -12.14 % 40.45 % 79.19 %
Y / Y Cash & cash equivalent Growth -54.43 % -41.71 % 86.42 % 81.99 % 92.18 %
Quick Ratio for Trailing Twelve Months Period 11.61 14.82 18.92 16.51 15.79
Total Ranking # 238 # # # #
Seq. Current Liabilities Growth 2.49 % 21.21 % -10.47 % 12.75 % 39.83 %
Seq. Cash & cash equivalent Growth -19.96 % -23.28 % -15.11 % -12.58 % 2.38 %

Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the II. Quarter to $26 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 11.61 below Atara Biotherapeutics, Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 31 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Atara Biotherapeutics. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 238.

What is Quick Ratio?
Learn more about ATRA
Quick Ratio ATRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 32
Sector # 98
S&P 500 # 230

Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.34 9.34 9.34
(Jun 30 2019)  

Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2019, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Eidos Therapeutics, Inc.  31.69 
Adverum Biotechnologies, Inc.  31.45 
Catalyst Biosciences, Inc.  28.49 
G1 Therapeutics, Inc.  21.91 
Voyager Therapeutics, Inc.  21.19 
Urogen Pharma Ltd.  19.74 
Iovance Biotherapeutics, inc.  18.83 
Acceleron Pharma Inc  18.63 
Casi Pharmaceuticals, Inc.  18.42 
Brickell Biotech, Inc.  18.33 
Homology Medicines, Inc.  17.33 
Aerpio Pharmaceuticals, Inc.  16.93 
Audentes Therapeutics, inc.  16.10 
Regenxbio Inc.  15.68 
Evelo Biosciences, Inc.  15.41 
Fennec Pharmaceuticals Inc.  15.34 
Crispr Therapeutics Ag  15.13 
Allena Pharmaceuticals, Inc.  13.93 
Unity Biotechnology, Inc.  13.53 
Atara Biotherapeutics, Inc.  12.77 
Arcus Biosciences, Inc.  12.61 
Myokardia Inc  12.24 
Salarius Pharmaceuticals, inc.  12.05 
Neoleukin Therapeutics, Inc.  11.80 
Organovo Holdings, Inc.  11.79 
Pulse Biosciences, Inc.  11.59 
Denali Therapeutics Inc.  11.23 
Eyenovia, Inc.  11.07 
Fulgent Genetics, Inc.  10.54 
Diffusion Pharmaceuticals Inc.  10.32 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

RCON's Profile

Stock Price

RCON's Financials

Business Description


Charts & Quotes

RCON's News


RCON's Competitors

Customers & Markets

Economic Indicators

RCON's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071